Fig. 5From: Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosisReceiver operating characteristic (ROC) curves comparison of pathway-based model and metabolites-based model among data sets. The same 80Â % of early stage (stage I and II) cases and controls from the COH plasma data set used in the early-stage diagnosis model were used for the plasma training set. The remaining 20Â % of early stage (stage I and II) cases and controls represent the test set. The metabolite-based model is based on the same tenfold cross-validation CFS selection used for the plasma training set. ROC curves for training and test sets are compared between the plasma-based model and the metabolite-based model among data setsBack to article page